SHILPAMED.NSE

Shilpa Medicare Ltd.

Costa Rica-based specialty healthcare company SteinCares has signed a licensing agreement with India’s Shilpa Biologicals, part of Shilpa Medicare, to commercialize a biosimilar across Latin America.

Shilpa Medicare Limited - 11/21/2025. Country: India. Record Type: 483

Indian pharmaceutical stocks, including Lupin, Shilpa Medicare, and Natco Pharma, are under scrutiny following recent USFDA inspections at their manufacturing sites. These audits yielded regulatory observations, prompting companies to address the findings. Alkem Laboratories, however, reported no critical issues from a separate Armenian health ministry audit at its Sikkim facility.

RAICHUR, India , Nov. 11, 2025 /PRNewswire/ -- Shilpa Pharma Lifesciences Limited, a material subsidiary of Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), has been awarded the prestigious Gold Medal by EcoVadis , the world's most trusted provider of business sustainability ratings. The company achieved an exceptional score of 82/100 , placing it in the 98th percentile globally among 130,000 + companies evaluated by EcoVadis. This performance underscores our industry-leading Environmental, Social and Governance (ESG) practices and reflects our long-term commitment to building a responsible, resilient, and sustainable pharmaceutical enterprise. EcoVadis assesses organizations on four key pillars — Environment, Labor & Human Rights, Ethics, and Sustainable Procurement — and this recognition positions Shilpa Pharma Lifesciences among the top few global companies rated for sustainable business operations. Speaking on this milestone, Mr. Keshav Bhutada , ED & CEO of Shilpa Pharma Lifesciences emphasized that "Sustainability and innovation are integral to Shilpa's CDMO growth strategy to work with global innovator companies for their New chemical Entity programs.